Search｜Photos & Images & Videos｜KYODO NEWS IMAGES INC

Japanese winners of U.S. Lasker Award

Composite photo shows Japanese Lasker Award winners (from L) Takehisa Kitazawa, Kunihiro Hattori and Tomoyuki Igawa of Chugai Pharmaceutical Co., and Masashi Yanagisawa, a professor at the University of Tsukuba. The Chugai researchers received the clinical medical research award for developing a hemophilia treatment, while Yanagisawa won the basic medical research award for identifying orexin and linking its deficiency to narcolepsy.

E

Japanese winners of U.S. Lasker Award

TOKYO, Japan, Sept. 10 Kyodo - Japanese researchers Takehisa Kitazawa, Kunihiro Hattori and Tomoyuki Igawa of Chugai Pharmaceutical Co. attend a press conference in Tokyo on Sept. 10, 2026, after receiving the Lasker Award for clinical medical research for their contributions to the development of a treatment for hemophilia. (Kyodo)

E

Japanese winner of U.S. Lasker Award

Japanese researcher Takehisa Kitazawa of Chugai Pharmaceutical Co. attends a press conference in Tokyo on Sept. 10, 2026, after receiving the Lasker Award for clinical medical research. Kitazawa shared the award with fellow Chugai researchers Kunihiro Hattori and Tomoyuki Igawa for their contributions to the development of a treatment for hemophilia.

E

Japanese winner of U.S. Lasker Award

Japanese researcher Tomoyuki Igawa of Chugai Pharmaceutical Co. attends a press conference in Tokyo on Sept. 10, 2026, after receiving the Lasker Award for clinical medical research. Kitazawa shared the award with fellow Chugai researchers Kunihiro Hattori and Takehisa Kitazawa for their contributions to the development of a treatment for hemophilia.

E

Japanese winner of U.S. Lasker Award

Japanese researcher Kunihiro Hattori of Chugai Pharmaceutical Co. attends a press conference in Tokyo on Sept. 10, 2026, after receiving the Lasker Award for clinical medical research. Hattori shared the award with fellow Chugai researchers Takehisa Kitazawa and Tomoyuki Igawa for their contributions to the development of a treatment for hemophilia.

E

Japanese winners of U.S. Lasker Award

(From L) Japanese researchers Takehisa Kitazawa, Kunihiro Hattori and Tomoyuki Igawa of Chugai Pharmaceutical Co. pose for a photo during a press conference in Tokyo on Sept. 10, 2026, after receiving the Lasker Award for clinical medical research for their contributions to the development of a treatment for hemophilia.

E

Japanese winners of U.S. Lasker Award

(From L) Japanese researchers Takehisa Kitazawa, Kunihiro Hattori and Tomoyuki Igawa of Chugai Pharmaceutical Co. pose for a photo during a press conference in Tokyo on Sept. 10, 2026, after receiving the Lasker Award for clinical medical research for their contributions to the development of a treatment for hemophilia.

E

Japanese winners of U.S. Lasker Award

(From L) Japanese researchers Takehisa Kitazawa, Kunihiro Hattori and Tomoyuki Igawa of Chugai Pharmaceutical Co. pose for a photo during a press conference in Tokyo on Sept. 10, 2026, after receiving the Lasker Award for clinical medical research for their contributions to the development of a treatment for hemophilia.

E

Japanese winners of U.S. Lasker Award

(From L) Japanese researchers Takehisa Kitazawa, Kunihiro Hattori and Tomoyuki Igawa of Chugai Pharmaceutical Co. attend a press conference in Tokyo on Sept. 10, 2026, after receiving the Lasker Award for clinical medical research for their contributions to the development of a treatment for hemophilia.

E

Japanese winners of U.S. Lasker Award

(From L) Japanese researchers Takehisa Kitazawa, Kunihiro Hattori and Tomoyuki Igawa of Chugai Pharmaceutical Co. attend a press conference in Tokyo on Sept. 10, 2026, after receiving the Lasker Award for clinical medical research for their contributions to the development of a treatment for hemophilia.

E

Japanese winners of U.S. Lasker Award

(From L) Japanese researchers Takehisa Kitazawa, Kunihiro Hattori and Tomoyuki Igawa of Chugai Pharmaceutical Co. attend a press conference in Tokyo on Sept. 10, 2026, after receiving the Lasker Award for clinical medical research for their contributions to the development of a treatment for hemophilia.

E

Professor Joyeux Is On Trial For Conducting "Unauthorized" Clinical Experiments - Paris

Professor Henri Joyeux is on trial for conducting "unauthorized" clinical experiments. Four people, including Henri Joyeux and Jean-Bernard Fourtillan, are on trial starting Monday, 8 December, before the Paris Criminal Court in the case of ‘unauthorised’ clinical experiments conducted on patients with Parkinson's and Alzheimer's disease, in Paris on December 8, 2025. Photo by Florian Poitout./ABACAPRESS.COM

E

Professor Joyeux Is On Trial For Conducting "Unauthorized" Clinical Experiments - Paris

Professor Henri Joyeux is on trial for conducting "unauthorized" clinical experiments. Four people, including Henri Joyeux and Jean-Bernard Fourtillan, are on trial starting Monday, 8 December, before the Paris Criminal Court in the case of ‘unauthorised’ clinical experiments conducted on patients with Parkinson's and Alzheimer's disease, in Paris on December 8, 2025. Photo by Florian Poitout./ABACAPRESS.COM

E

Professor Joyeux Is On Trial For Conducting "Unauthorized" Clinical Experiments - Paris

Professor Henri Joyeux is on trial for conducting "unauthorized" clinical experiments. Four people, including Henri Joyeux and Jean-Bernard Fourtillan, are on trial starting Monday, 8 December, before the Paris Criminal Court in the case of ‘unauthorised’ clinical experiments conducted on patients with Parkinson's and Alzheimer's disease, in Paris on December 8, 2025. Photo by Florian Poitout./ABACAPRESS.COM

E

Professor Joyeux Is On Trial For Conducting "Unauthorized" Clinical Experiments - Paris

Professor Henri Joyeux is on trial for conducting "unauthorized" clinical experiments. Four people, including Henri Joyeux and Jean-Bernard Fourtillan, are on trial starting Monday, 8 December, before the Paris Criminal Court in the case of ‘unauthorised’ clinical experiments conducted on patients with Parkinson's and Alzheimer's disease, in Paris on December 8, 2025. Photo by Florian Poitout./ABACAPRESS.COM

E

Professor Joyeux Is On Trial For Conducting "Unauthorized" Clinical Experiments - Paris

Professor Henri Joyeux is on trial for conducting "unauthorized" clinical experiments. Four people, including Henri Joyeux and Jean-Bernard Fourtillan, are on trial starting Monday, 8 December, before the Paris Criminal Court in the case of ‘unauthorised’ clinical experiments conducted on patients with Parkinson's and Alzheimer's disease, in Paris on December 8, 2025. Photo by Florian Poitout./ABACAPRESS.COM

E

Professor Joyeux Is On Trial For Conducting "Unauthorized" Clinical Experiments - Paris

Professor Henri Joyeux is on trial for conducting "unauthorized" clinical experiments. Four people, including Henri Joyeux and Jean-Bernard Fourtillan, are on trial starting Monday, 8 December, before the Paris Criminal Court in the case of ‘unauthorised’ clinical experiments conducted on patients with Parkinson's and Alzheimer's disease, in Paris on December 8, 2025. Photo by Florian Poitout./ABACAPRESS.COM

E

Professor Joyeux Is On Trial For Conducting "Unauthorized" Clinical Experiments - Paris

Professor Henri Joyeux is on trial for conducting "unauthorized" clinical experiments. Four people, including Henri Joyeux and Jean-Bernard Fourtillan, are on trial starting Monday, 8 December, before the Paris Criminal Court in the case of ‘unauthorised’ clinical experiments conducted on patients with Parkinson's and Alzheimer's disease, in Paris on December 8, 2025. Photo by Florian Poitout./ABACAPRESS.COM

E

Professor Joyeux Is On Trial For Conducting "Unauthorized" Clinical Experiments - Paris

Professor Henri Joyeux is on trial for conducting "unauthorized" clinical experiments. Four people, including Henri Joyeux and Jean-Bernard Fourtillan, are on trial starting Monday, 8 December, before the Paris Criminal Court in the case of ‘unauthorised’ clinical experiments conducted on patients with Parkinson's and Alzheimer's disease, in Paris on December 8, 2025. Photo by Florian Poitout./ABACAPRESS.COM

E

Professor Joyeux Is On Trial For Conducting "Unauthorized" Clinical Experiments - Paris

Professor Henri Joyeux is on trial for conducting "unauthorized" clinical experiments. Four people, including Henri Joyeux and Jean-Bernard Fourtillan, are on trial starting Monday, 8 December, before the Paris Criminal Court in the case of ‘unauthorised’ clinical experiments conducted on patients with Parkinson's and Alzheimer's disease, in Paris on December 8, 2025. Photo by Florian Poitout./ABACAPRESS.COM

E

Professor Joyeux Is On Trial For Conducting "Unauthorized" Clinical Experiments - Paris

Professor Henri Joyeux is on trial for conducting "unauthorized" clinical experiments. Four people, including Henri Joyeux and Jean-Bernard Fourtillan, are on trial starting Monday, 8 December, before the Paris Criminal Court in the case of ‘unauthorised’ clinical experiments conducted on patients with Parkinson's and Alzheimer's disease, in Paris on December 8, 2025. Photo by Florian Poitout./ABACAPRESS.COM

E

2025 WAIC Held in Shanghai

The AI healthcare achievement showcased by Lanxiang Digital Technology at the 2025 WAIC World Artificial Intelligence Conference - the "Digital Twin Clinical Healthcare" AI agent for critical care specialty, Shanghai, China on July 26, 2025.

E

Laurent Marcangeli visits Institut Gustave Roussy near Paris FA

Benjamin Besse, Director of Clinical Research at Gustave Roussy speaks as French Minister for Public Action, Civil Service and Simplification Laurent Marcangeli visits Institut Gustave Roussy in Villejuif near Paris on April 7, 2025. Photo by Firas Abdullah/ABACAPRESS.COM

E

Laurent Marcangeli visits Institut Gustave Roussy near Paris FA

Benjamin Besse, Director of Clinical Research at Gustave Roussy speaks as French Minister for Public Action, Civil Service and Simplification Laurent Marcangeli visits Institut Gustave Roussy in Villejuif near Paris on April 7, 2025. Photo by Firas Abdullah/ABACAPRESS.COM

E

Laurent Marcangeli visits Institut Gustave Roussy near Paris FA

Benjamin Besse, Director of Clinical Research at Gustave Roussy speaks as French Minister for Public Action, Civil Service and Simplification Laurent Marcangeli visits Institut Gustave Roussy in Villejuif near Paris on April 7, 2025. Photo by Firas Abdullah/ABACAPRESS.COM

E

Laurent Marcangeli visits Institut Gustave Roussy near Paris FA

Benjamin Besse, Director of Clinical Research at Gustave Roussy speaks as French Minister for Public Action, Civil Service and Simplification Laurent Marcangeli visits Institut Gustave Roussy in Villejuif near Paris on April 7, 2025. Photo by Firas Abdullah/ABACAPRESS.COM

E

Laurent Marcangeli visits Institut Gustave Roussy near Paris FA

Benjamin Besse, Director of Clinical Research at Gustave Roussy looks on as French Minister for Public Action, Civil Service and Simplification Laurent Marcangeli visits Institut Gustave Roussy in Villejuif near Paris on April 7, 2025. Photo by Firas Abdullah/ABACAPRESS.COM

E

Queen Letizia Visit To CIMCYC - Granada

Queen Letizia visits the Mind, Brain and Behavior Research Center (CIMCYC) of the University of Granada. On April 1, 2025, in Granada (Andalusia, Spain). Queen Letizia has come to Granada on the occasion of the presentation of the Chair in Psycho-Neuro-Immunology-Clinical, a science that studies the interaction and communication between the different body systems. Photo by Álex Camara/Europa Press/ABACAPRESS.COM

E

Queen Letizia Visit To CIMCYC - Granada

Queen Letizia (left) visits the Mind, Brain and Behavior Research Center (CIMCYC) of the University of Granada. On April 1, 2025, in Granada (Andalusia, Spain). Queen Letizia has come to Granada on the occasion of the presentation of the Chair in Psycho-Neuro-Immunology-Clinical, a science that studies the interaction and communication between the different body systems. Photo by Álex Camara/Europa Press/ABACAPRESS.COM

E

Queen Letizia Visit To CIMCYC - Granada

Queen Letizia visits the Mind, Brain and Behavior Research Center (CIMCYC) of the University of Granada. On April 1, 2025, in Granada (Andalusia, Spain). Queen Letizia has come to Granada on the occasion of the presentation of the Chair in Psycho-Neuro-Immunology-Clinical, a science that studies the interaction and communication between the different body systems. Photo by Álex Camara/Europa Press/ABACAPRESS.COM

E

Queen Letizia Visit To CIMCYC - Granada

Queen Letizia (left) visits the Mind, Brain and Behavior Research Center (CIMCYC) of the University of Granada. On April 1, 2025, in Granada (Andalusia, Spain). Queen Letizia has come to Granada on the occasion of the presentation of the Chair in Psycho-Neuro-Immunology-Clinical, a science that studies the interaction and communication between the different body systems. Photo by Álex Camara/Europa Press/ABACAPRESS.COM

E

Queen Letizia Visit To CIMCYC - Granada

Queen Letizia visits the Mind, Brain and Behavior Research Center (CIMCYC) of the University of Granada. On April 1, 2025, in Granada (Andalusia, Spain). Queen Letizia has come to Granada on the occasion of the presentation of the Chair in Psycho-Neuro-Immunology-Clinical, a science that studies the interaction and communication between the different body systems. Photo by Álex Camara/Europa Press/ABACAPRESS.COM

E

Queen Letizia Visit To CIMCYC - Granada

Queen Letizia visits the Mind, Brain and Behavior Research Center (CIMCYC) of the University of Granada. On April 1, 2025, in Granada (Andalusia, Spain). Queen Letizia has come to Granada on the occasion of the presentation of the Chair in Psycho-Neuro-Immunology-Clinical, a science that studies the interaction and communication between the different body systems. Photo by Álex Camara/Europa Press/ABACAPRESS.COM

E

Queen Letizia Visit To CIMCYC - Granada

Queen Letizia visits the Mind, Brain and Behavior Research Center (CIMCYC) of the University of Granada. On April 1, 2025, in Granada (Andalusia, Spain). Queen Letizia has come to Granada on the occasion of the presentation of the Chair in Psycho-Neuro-Immunology-Clinical, a science that studies the interaction and communication between the different body systems. Photo by Álex Camara/Europa Press/ABACAPRESS.COM

E

Queen Letizia Visit To CIMCYC - Granada

Queen Letizia visits the Mind, Brain and Behavior Research Center (CIMCYC) of the University of Granada. On April 1, 2025, in Granada (Andalusia, Spain). Queen Letizia has come to Granada on the occasion of the presentation of the Chair in Psycho-Neuro-Immunology-Clinical, a science that studies the interaction and communication between the different body systems. Photo by Álex Camara/Europa Press/ABACAPRESS.COM

E

Queen Letizia Visit To CIMCYC - Granada

Queen Letizia (c) and the Mayoress of Granada, Marifrán Carazo (l), visit the Mind, Brain and Behavior Research Center (CIMCYC) of the University of Granada. On April 1, 2025, in Granada (Andalusia, Spain). Queen Letizia has come to Granada on the occasion of the presentation of the Chair in Psycho-Neuro-Immunology-Clinical, a science that studies the interaction and communication between the different body systems. Photo by Álex Camara/Europa Press/ABACAPRESS.COM

E

Queen Letizia Visit To CIMCYC - Granada

Detail of Queen Letizia's handbag during her visit to the Mind, Brain and Behavior Research Center (CIMCYC) of the University of Granada. On April 1, 2025, in Granada (Andalusia, Spain). Queen Letizia has come to Granada on the occasion of the presentation of the Chair in Psycho-Neuro-Immunology-Clinical, a science that studies the interaction and communication between the different body systems. Photo by Álex Camara/Europa Press/ABACAPRESS.COM

E

Queen Letizia Visit To CIMCYC - Granada

Detail of Queen Letizia's shoes, during the visit to the Mind, Brain and Behavior Research Center (CIMCYC) of the University of Granada. On April 1, 2025, in Granada (Andalusia, Spain). Queen Letizia has come to Granada on the occasion of the presentation of the Chair in Psycho-Neuro-Immunology-Clinical, a science that studies the interaction and communication between the different body systems. Photo by Álex Camara/Europa Press/ABACAPRESS.COM

E

Queen Letizia Visit To CIMCYC - Granada

Queen Letizia visits the Mind, Brain and Behavior Research Center (CIMCYC) of the University of Granada. On April 1, 2025, in Granada (Andalusia, Spain). Queen Letizia has come to Granada on the occasion of the presentation of the Chair in Psycho-Neuro-Immunology-Clinical, a science that studies the interaction and communication between the different body systems. Photo by Álex Camara/Europa Press/ABACAPRESS.COM

E

Doctors save severely wounded soldiers from front line in Dnipro

A medical worker tends to the patient in the ward of the polytrauma intensive care unit at the Illia Mechnykov Dnipro Regional Clinical Hospital, Dnipro, Ukraine, on 14 March 2025 (Photo by Dmytro Smolienko/Ukrinform)

E

Doctors save severely wounded soldiers from front line in Dnipro

Women tend to a serviceman on a gurney in the polytrauma intensive care unit at the Illia Mechnykov Dnipro Regional Clinical Hospital, Dnipro, Ukraine, on 14 March 2025 (Photo by Dmytro Smolienko/Ukrinform)

E

Doctors save severely wounded soldiers from front line in Dnipro

A medical worker and patients are seen in the ward of the polytrauma intensive care unit at the Illia Mechnykov Dnipro Regional Clinical Hospital, Dnipro, Ukraine, on 14 March 2025 (Photo by Dmytro Smolienko/Ukrinform)

E

Doctors save severely wounded soldiers from front line in Dnipro

A medical worker tends to the wounded soldier with the call sign "Mechanic" in the ward of the polytrauma intensive care unit at the Illia Mechnykov Dnipro Regional Clinical Hospital, Dnipro, Ukraine, on 14 March 2025 (Photo by Dmytro Smolienko/Ukrinform)

E

Doctors save severely wounded soldiers from front line in Dnipro

A medical worker tends to the patient in the ward of the polytrauma intensive care unit at the Illia Mechnykov Dnipro Regional Clinical Hospital, Dnipro, Ukraine, on 14 March 2025 (Photo by Dmytro Smolienko/Ukrinform)

E

Doctors save severely wounded soldiers from front line in Dnipro

A medical worker tends to the wounded soldier with the call sign "Mechanic" in the ward of the polytrauma intensive care unit at the Illia Mechnykov Dnipro Regional Clinical Hospital, Dnipro, Ukraine, on 14 March 2025 (Photo by Dmytro Smolienko/Ukrinform)

E

Doctors save severely wounded soldiers from front line in Dnipro

Paients are seen in the ward of the polytrauma intensive care unit at the Illia Mechnykov Dnipro Regional Clinical Hospital, Dnipro, Ukraine, on 14 March 2025 (Photo by Dmytro Smolienko/Ukrinform)

E

Doctors save severely wounded soldiers from front line in Dnipro

A medical worker tends to the wounded soldier with the call sign "Mechanic" in the ward of the polytrauma intensive care unit at the Illia Mechnykov Dnipro Regional Clinical Hospital, Dnipro, Ukraine, on 14 March 2025 (Photo by Dmytro Smolienko/Ukrinform)

E

Doctors save severely wounded soldiers from front line in Dnipro

Serviceman with the call sign "Mechanic" is seen in the ward of the polytrauma intensive care unit at the Illia Mechnykov Dnipro Regional Clinical Hospital, Dnipro, Ukraine, on 14 March 2025 (Photo by Dmytro Smolienko/Ukrinform)

E

Doctors save severely wounded soldiers from front line in Dnipro

A medical worker tends to the patient in the ward of the polytrauma intensive care unit at the Illia Mechnykov Dnipro Regional Clinical Hospital, Dnipro, Ukraine, on 14 March 2025 (Photo by Dmytro Smolienko/Ukrinform)

E

Doctors save severely wounded soldiers from front line in Dnipro

Paients are seen in the ward of the polytrauma intensive care unit at the Illia Mechnykov Dnipro Regional Clinical Hospital, Dnipro, Ukraine, on 14 March 2025 (Photo by Dmytro Smolienko/Ukrinform)